Ladenburg Thalmann Financial Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $360K | Buy |
4,344
+370
| +9% | +$30.7K | ﹤0.01% | 2071 |
|
|
2019
Q3 | $267K | Buy |
3,974
+88
| +2% | +$5.91K | ﹤0.01% | 2255 |
|
|
2019
Q2 | $335K | Sell |
3,886
-4,502
| -54% | -$388K | ﹤0.01% | 2057 |
|
|
2019
Q1 | $745K | Buy |
8,388
+692
| +9% | +$61.5K | 0.01% | 1385 |
|
|
2018
Q4 | $659K | Buy |
7,696
+3,546
| +85% | +$304K | 0.01% | 1339 |
|
|
2018
Q3 | $402K | Buy |
4,150
+472
| +13% | +$45.7K | ﹤0.01% | 1776 |
|
|
2018
Q2 | $299K | Hold |
3,678
| – | – | ﹤0.01% | 1934 |
|
|
2018
Q1 | $299K | Buy |
3,678
+454
| +14% | +$36.9K | ﹤0.01% | 1934 |
|
|
2017
Q4 | $287K | Buy |
3,224
+600
| +23% | +$53.4K | ﹤0.01% | 1925 |
|
|
2017
Q3 | $244K | Buy |
2,624
+39
| +2% | +$3.63K | ﹤0.01% | 1955 |
|
|
2017
Q2 | $235K | Sell |
2,585
-141
| -5% | -$12.8K | ﹤0.01% | 1899 |
|
|
2017
Q1 | $239K | Buy |
2,726
+139
| +5% | +$12.2K | ﹤0.01% | 1788 |
|
|
2016
Q4 | $215K | Sell |
2,587
-18
| -0.7% | -$1.5K | ﹤0.01% | 1775 |
|
|
2016
Q3 | $241K | Sell |
2,605
-53
| -2% | -$4.9K | ﹤0.01% | 1628 |
|
|
2016
Q2 | $207K | Buy |
2,658
+213
| +9% | +$16.6K | ﹤0.01% | 1657 |
|
|
2016
Q1 | $202K | Buy |
2,445
+450
| +23% | +$37.2K | ﹤0.01% | 1601 |
|
|
2015
Q4 | $209K | Sell |
1,995
-378
| -16% | -$39.6K | ﹤0.01% | 1550 |
|
|
2015
Q3 | $250K | Sell |
2,373
-328
| -12% | -$34.6K | 0.01% | 1333 |
|
|
2015
Q2 | $370K | Buy |
2,701
+600
| +29% | +$82.2K | 0.01% | 1212 |
|
|
2015
Q1 | $261K | Sell |
2,101
-413
| -16% | -$51.3K | 0.01% | 1396 |
|
|
2014
Q4 | $227K | Sell |
2,514
-513
| -17% | -$46.3K | 0.01% | 1335 |
|
|
2014
Q3 | $218K | Buy |
3,027
+1,760
| +139% | +$127K | 0.01% | 1174 |
|
|
2014
Q2 | $79K | Buy |
1,267
+311
| +33% | +$19.4K | ﹤0.01% | 1742 |
|
|
2014
Q1 | $65K | Sell |
956
-70
| -7% | -$4.76K | ﹤0.01% | 1771 |
|
|
2013
Q4 | $72K | Buy |
1,026
+28
| +3% | +$1.97K | ﹤0.01% | 1667 |
|
|
2013
Q3 | $71K | Buy |
998
+78
| +8% | +$5.55K | ﹤0.01% | 1590 |
|
|
2013
Q2 | $53K | Buy |
+920
| New | +$53K | ﹤0.01% | 1701 |
|